Novel autism subtype
A novel precision medicine approach enhanced by artificial intelligence has laid the groundwork for what could be the first biomedical screening and intervention tool for a subtype of autism, reports a new study. The approach is believed to be the first of its kind. Today, autism is diagnosed based only on symptoms and by the time a physician identifies it, it’s often when early and critical brain developmental windows have passed without appropriate intervention. This discovery could shift that paradigm.
![[branded content] De vijf belangrijkste customer experience trends voor 2024](https://www.pharmamarketeer.nl/wp-content/uploads/2024/04/customer-experience-80x60.jpg)
